Abstract 5260: Combination activity of eribulin liposomal formulation and anti-PD-1 antibody after tumor regrowth during anti-PD-1 antibody treatment in mice
Authors: Moe Tamura, Yuki Niwa, Taro Semba
Published: 2024-03-22
DOI:
10.1158/1538-7445.am2024-5260
Source:
Full article
Abstract
Abstract